[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575291":3},{"organization":4,"armGroups":7,"interventions":23,"overallOfficials":40,"centralContacts":51,"locations":58,"responsibleParty":84,"collaborators":88,"id":94,"slug":95,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":100,"eligibilityCriteria":101,"healthyVolunteers":96,"sex":102,"minAge":103,"maxAge":40,"enrollmentInfo":104,"targetDuration":40,"studyType":107,"phases":108,"briefSummary":110,"conditions":111,"keywords":116,"overallStatus":61,"whyStopped":40,"lastUpdateSubmitDate":123,"lastUpdatePostDateStruct":124,"startDateStruct":127,"completionDateStruct":129,"leadSponsor":131,"locationsCount":132},{"fullName":5,"class":6},"Hospital Arnau de Vilanova","OTHER",[8,17],{"label":9,"type":10,"description":11,"interventionNames":12},"Control","ACTIVE_COMPARATOR","After cannulation of a midline or peripherally inserted central venous catheter with modified micro-Seldinger technique, the control group underwent standard care.",[13,14,15,16],"Procedure: Control group: acrylic adhesive sutureless fixation device","Device: PICC","Device: Midline","Other: Ultrasound scanner",{"label":18,"type":19,"description":20,"interventionNames":21},"Intervention","EXPERIMENTAL","After cannulation of a midline or peripherally inserted central venous catheter with modified micro-Seldinger technique, the intervention group underwent the alternative care.",[22,14,15,16],"Procedure: Intervention Group: zinc oxide sutureless fixation device",[24,30,35,41,45],{"type":25,"name":26,"description":27,"armGroupLabels":28,"otherNames":29},"PROCEDURE","Control group: acrylic adhesive sutureless fixation device","The standard care consists of:\n\n* Application of hemostasis at the point of insertion for 2 minutes post puncture or until bleeding stops.\n* Fix with clear polyurethane dressing (3M®-1655 Tegaderm™ IV), cyanoacrylate glue (SecurePortIV®) and acrylic adhesive sutureless fixation device (3300MWA Grip-Lok®).",[9],[9],{"type":25,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"Intervention Group: zinc oxide sutureless fixation device","Alternative care consisted of:\n\n* Application of haemostasis at the insertion site for 2 minutes post-puncture or until cessation of bleeding.\n* Fixation with clear polyurethane dressing (3M®-1655 Tegaderm™ IV), cyanoacrylate glue (SecurePortIV®) and zinc oxide sutureless fixation device (2200NUZA Grip-Lok®).",[18],[18],{"type":36,"name":37,"description":38,"armGroupLabels":39,"otherNames":40},"DEVICE","PICC","The PICC lines used in the study will all be third-generation polyurethane and of the commercial brands:\n\n* PowerPICC™ 4, 5 and 6 Fr from BD\n* Maxflo expert™ 5 and 6 Fr from Vygon",[9,18],null,{"type":36,"name":42,"description":43,"armGroupLabels":44,"otherNames":40},"Midline","The midline lines used in the study will be second or third generation polyurethane and of the commercial brands:\n\n* PowerMidline™ 4 Fr from BD\n* Arrow® Midline 4Fr from Arrow",[9,18],{"type":6,"name":46,"description":47,"armGroupLabels":48,"otherNames":49},"Ultrasound scanner","All punctures will be performed under ultrasound guidance.",[9,18],[50],"Ultrasound",[52],{"name":53,"role":54,"phone":55,"phoneExt":56,"email":57},"Padilla-Nula F PhD candidate, Nurse","CONTACT","+ 34 973 24 81 00","8 4169","FPADILLA@gencat.cat",[59,77],{"facility":60,"status":61,"city":62,"state":63,"zip":64,"country":65,"countryCode":66,"cosmosGeoPoint":67,"geoPoint":72,"contacts":73},"Arnau de Vilanova Hospital","RECRUITING","Lleida","Catalonia","25001","Spain","ES",{"type":68,"coordinates":69},"Point",[70,71],0.62218,41.61674,{"lat":71,"lon":70},[74],{"name":75,"role":54,"phone":76,"phoneExt":40,"email":57},"Padilla-Nula F, Nursing graduat","973 24 81 00",{"facility":78,"status":79,"city":62,"state":63,"zip":80,"country":65,"countryCode":66,"cosmosGeoPoint":81,"geoPoint":83,"contacts":40},"Hospital Universitari Arnau de Vilanova","COMPLETED","25198",{"type":68,"coordinates":82},[70,71],{"lat":71,"lon":70},{"type":85,"investigatorFullName":86,"investigatorTitle":87,"investigatorAffiliation":5,"oldNameTitle":40,"oldOrganization":40},"PRINCIPAL_INVESTIGATOR","Ferran Padilla Nula","Principal Investigator",[89,92],{"name":90,"class":91},"Official College of Nurses of Lleida","UNKNOWN",{"name":93,"class":91},"Department of Health, Generalitat de Catalunya (PERIS)","100575291","effectiveness-of-a-zinc-oxide-adhesive-securement-device-in-the-fixation-of-midline-and-peripherally-inserted-central-catheters-in-hospitalized-adult-patients-100575291",false,"NCT06770374","Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients","Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients: Randomised Clinical Trial","FIX-ETI","Inclusion Criteria:\n\n* requiring cannulation of a midline catheter or a PICC\n* who accepted and signed the informed consent voluntarily\n* with an inpatient unit admission of minimum 7 days\n\nExclusion Criteria:\n\n\\- patients with a known allergy to zinc oxide","ALL","18 Years",{"count":105,"type":106},400,"ESTIMATED","INTERVENTIONAL",[109],"NA","Study in which a zinc oxide fixation device (a product that can help protect the skin) for catheters (polyurethane tubes inserted into a vein) will be tested to reduce catheter-related complications: catheter displacement, skin complications, phlebitis and pain..",[112,113,114,115],"Vascular Access Complication","Skin and Subcutaneous Tissue Disorders","Phlebitis","Pain",[117,118,119,120,121,122],"Catheters","Vascular Access Devices","Catheter-Related Infections","Nurse Specialists","Nurses","Randomised Controlled Trial","2026-04-02",{"date":125,"type":126},"2026-04-08","ACTUAL",{"date":128,"type":126},"2025-02-01",{"date":130,"type":106},"2026-12-31",{"name":5,"class":6},2]